Specific cancer-associated mutations in the switch III region of Ras increase tumorigenicity by nanocluster augmentation
Maja Šolman(University Medical Center Utrecht), Daniel Abankwa(University of Luxembourg)
Cited by 50
Related Papers
SPRED1 Interferes with K-ras but Not H-ras Membrane Anchorage and Signaling
|Molecular and Cellular Biology|2016|25
Rapalogs can promote cancer cell stemness <i>in vitro</i> in a Galectin-1 and H-ras-dependent manner
|Oncotarget|2017|23
An Improved PDE6D Inhibitor Combines with Sildenafil To Inhibit <i>KRAS</i> Mutant Cancer Cell Growth
|Journal of Medicinal Chemistry|2024|23
Potential of phenothiazines to synergistically block calmodulin and reactivate PP2A in cancer cells
|PLoS ONE|2022|18
Opposite feedback from mTORC1 to H-ras and K-ras4B downstream of SREBP1
|Scientific Reports|2017|14